Last reviewed · How we verify
NCT04832828
Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive
trial testing Roth´s Test in Covid19 in 114 participants. Completed in 28 November 2020.
28 November 2020
Quick facts
| Lead sponsor | Universidad Autonoma de Madrid |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 114 |
| Start date | 1 June 2020 |
| Primary completion | 28 November 2020 |
| Estimated completion | 28 November 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Roth´s Test
Conditions studied
- Covid19 — all drugs for Covid19 →
Sponsor
Universidad Autonoma de Madrid — full company profile →
Who can join
Adults 12 to 99, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights the need for valid tools to assess respiratory capacity. The Roth test has been associated with acceptable sensitivity and specificity criteria in patients with previous respiratory pathology; however, its validity in this type of patient has not been proven.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04832828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Universidad Autonoma de Madrid trials
Trials by the same sponsor.
- NCT07090434 — Effect of Bei App for Fibromyalgia · NA · not yet recruiting
- NCT06726447 — Artificial Intelligence Satisfaction in Professionals and Patients · NA · recruiting
- NCT06601478 — Development and Implementation of a Tool for the Evaluation and Monitoring of the Mediterranean Lifestyle in the Clinica · NA · recruiting
- NCT05623579 — Education on BDNF on Pain Levels · NA · unknown
- NCT05736172 — 3h of PNE on BDNF and Pain Levels · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04832828 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Madrid
- Last refreshed: 6 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04832828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing